GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
CBFB
|
ENSG00000067955.9 | core-binding factor subunit beta |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CBFB | hg19_v2_chr16_+_67062996_67063019 | 0.25 | 2.6e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_114310237 | 12.86 |
ENST00000539119.1
|
REXO2
|
RNA exonuclease 2 |
chr11_+_114310102 | 12.54 |
ENST00000265881.5
|
REXO2
|
RNA exonuclease 2 |
chr11_+_114310164 | 12.20 |
ENST00000544196.1
ENST00000539754.1 ENST00000539275.1 |
REXO2
|
RNA exonuclease 2 |
chr3_-_99569821 | 6.46 |
ENST00000487087.1
|
FILIP1L
|
filamin A interacting protein 1-like |
chr2_-_64881018 | 5.22 |
ENST00000313349.3
|
SERTAD2
|
SERTA domain containing 2 |
chr5_-_137878887 | 5.09 |
ENST00000507939.1
ENST00000572514.1 ENST00000499810.2 ENST00000360541.5 |
ETF1
|
eukaryotic translation termination factor 1 |
chr3_+_157154578 | 4.36 |
ENST00000295927.3
|
PTX3
|
pentraxin 3, long |
chr17_+_32582293 | 4.31 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
chr3_-_189840223 | 3.77 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
chr10_-_29811456 | 3.75 |
ENST00000535393.1
|
SVIL
|
supervillin |
chr11_+_18343800 | 2.76 |
ENST00000453096.2
|
GTF2H1
|
general transcription factor IIH, polypeptide 1, 62kDa |
chr12_-_4754339 | 2.67 |
ENST00000228850.1
|
AKAP3
|
A kinase (PRKA) anchor protein 3 |
chr11_-_66103867 | 2.32 |
ENST00000424433.2
|
RIN1
|
Ras and Rab interactor 1 |
chr11_-_18343669 | 2.24 |
ENST00000396253.3
ENST00000349215.3 ENST00000438420.2 |
HPS5
|
Hermansky-Pudlak syndrome 5 |
chr15_-_64665911 | 2.23 |
ENST00000606793.1
ENST00000561349.1 ENST00000560278.1 |
CTD-2116N17.1
|
Uncharacterized protein |
chr21_-_36421401 | 2.20 |
ENST00000486278.2
|
RUNX1
|
runt-related transcription factor 1 |
chr14_-_61116168 | 1.98 |
ENST00000247182.6
|
SIX1
|
SIX homeobox 1 |
chr19_-_14049184 | 1.96 |
ENST00000339560.5
|
PODNL1
|
podocan-like 1 |
chr19_-_14048804 | 1.92 |
ENST00000254320.3
ENST00000586075.1 |
PODNL1
|
podocan-like 1 |
chr7_+_120628731 | 1.87 |
ENST00000310396.5
|
CPED1
|
cadherin-like and PC-esterase domain containing 1 |
chr20_+_43343886 | 1.69 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr12_+_15125954 | 1.65 |
ENST00000266395.2
|
PDE6H
|
phosphodiesterase 6H, cGMP-specific, cone, gamma |
chr20_+_54987168 | 1.63 |
ENST00000360314.3
|
CASS4
|
Cas scaffolding protein family member 4 |
chr11_-_58343319 | 1.46 |
ENST00000395074.2
|
LPXN
|
leupaxin |
chr1_+_196621002 | 1.42 |
ENST00000367429.4
ENST00000439155.2 |
CFH
|
complement factor H |
chrX_-_49041242 | 1.42 |
ENST00000453382.1
ENST00000540849.1 ENST00000536904.1 ENST00000432913.1 |
PRICKLE3
|
prickle homolog 3 (Drosophila) |
chr20_+_54987305 | 1.35 |
ENST00000371336.3
ENST00000434344.1 |
CASS4
|
Cas scaffolding protein family member 4 |
chr3_+_98482175 | 1.26 |
ENST00000485391.1
ENST00000492254.1 |
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
chr21_-_36421626 | 1.26 |
ENST00000300305.3
|
RUNX1
|
runt-related transcription factor 1 |
chr1_-_179112173 | 1.23 |
ENST00000408940.3
ENST00000504405.1 |
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr21_-_36421535 | 1.23 |
ENST00000416754.1
ENST00000437180.1 ENST00000455571.1 |
RUNX1
|
runt-related transcription factor 1 |
chr1_+_196621156 | 1.18 |
ENST00000359637.2
|
CFH
|
complement factor H |
chr11_-_66104237 | 1.05 |
ENST00000530056.1
|
RIN1
|
Ras and Rab interactor 1 |
chr2_+_207024306 | 1.03 |
ENST00000236957.5
ENST00000392221.1 ENST00000392222.2 ENST00000445505.1 |
EEF1B2
|
eukaryotic translation elongation factor 1 beta 2 |
chr5_+_131409476 | 1.01 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr12_+_25205568 | 0.98 |
ENST00000548766.1
ENST00000556887.1 |
LRMP
|
lymphoid-restricted membrane protein |
chrX_-_153718988 | 0.98 |
ENST00000263512.4
ENST00000393587.4 ENST00000453912.1 |
SLC10A3
|
solute carrier family 10, member 3 |
chr6_+_52051171 | 0.88 |
ENST00000340057.1
|
IL17A
|
interleukin 17A |
chr4_+_74347400 | 0.85 |
ENST00000226355.3
|
AFM
|
afamin |
chr1_-_179112189 | 0.83 |
ENST00000512653.1
ENST00000344730.3 |
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr12_+_25205446 | 0.79 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
chrX_+_115567767 | 0.76 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
chr4_-_156297949 | 0.75 |
ENST00000515654.1
|
MAP9
|
microtubule-associated protein 9 |
chr9_-_35080013 | 0.70 |
ENST00000378643.3
|
FANCG
|
Fanconi anemia, complementation group G |
chr9_-_123342415 | 0.70 |
ENST00000349780.4
ENST00000360190.4 ENST00000360822.3 ENST00000359309.3 |
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2 |
chr1_+_89246647 | 0.67 |
ENST00000544045.1
|
PKN2
|
protein kinase N2 |
chr14_-_24977457 | 0.66 |
ENST00000250378.3
ENST00000206446.4 |
CMA1
|
chymase 1, mast cell |
chr6_-_34524093 | 0.65 |
ENST00000544425.1
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr1_+_39876151 | 0.62 |
ENST00000530275.1
|
KIAA0754
|
KIAA0754 |
chr5_+_35856951 | 0.61 |
ENST00000303115.3
ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr11_-_66103932 | 0.61 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
chr1_+_209859510 | 0.57 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr6_+_27925019 | 0.57 |
ENST00000244623.1
|
OR2B6
|
olfactory receptor, family 2, subfamily B, member 6 |
chr6_+_29068386 | 0.55 |
ENST00000377171.3
|
OR2J1
|
olfactory receptor, family 2, subfamily J, member 1 (gene/pseudogene) |
chr6_-_34524049 | 0.54 |
ENST00000374037.3
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr12_-_68553512 | 0.49 |
ENST00000229135.3
|
IFNG
|
interferon, gamma |
chr1_+_47264711 | 0.47 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
chr16_+_53088885 | 0.42 |
ENST00000566029.1
ENST00000447540.1 |
CHD9
|
chromodomain helicase DNA binding protein 9 |
chr15_+_49715293 | 0.34 |
ENST00000267843.4
ENST00000560270.1 |
FGF7
|
fibroblast growth factor 7 |
chr12_-_14849470 | 0.30 |
ENST00000261170.3
|
GUCY2C
|
guanylate cyclase 2C (heat stable enterotoxin receptor) |
chr6_+_45296391 | 0.19 |
ENST00000371436.6
ENST00000576263.1 |
RUNX2
|
runt-related transcription factor 2 |
chr1_-_184723942 | 0.18 |
ENST00000318130.8
|
EDEM3
|
ER degradation enhancer, mannosidase alpha-like 3 |
chr14_+_22748980 | 0.18 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
chr14_+_22919081 | 0.16 |
ENST00000390473.1
|
TRDJ1
|
T cell receptor delta joining 1 |
chr14_+_85996507 | 0.15 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chrX_-_70838306 | 0.11 |
ENST00000373691.4
ENST00000373693.3 |
CXCR3
|
chemokine (C-X-C motif) receptor 3 |
chr2_+_234826016 | 0.10 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
chr8_-_60031762 | 0.04 |
ENST00000361421.1
|
TOX
|
thymocyte selection-associated high mobility group box |
chr20_+_44637526 | 0.02 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr1_-_240775447 | 0.00 |
ENST00000318160.4
|
GREM2
|
gremlin 2, DAN family BMP antagonist |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.9 | 37.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.9 | 4.4 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.7 | 4.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 2.0 | GO:0061055 | myotome development(GO:0061055) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.5 | 2.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 5.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.3 | 4.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.7 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.2 | 1.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.2 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) lung goblet cell differentiation(GO:0060480) |
0.1 | 0.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 2.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.3 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 2.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 4.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 2.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.6 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 3.8 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 1.3 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 1.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 2.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.2 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.6 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.9 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 1.8 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 2.2 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 3.0 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 37.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 2.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 2.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 2.2 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 4.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 3.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 5.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.8 | GO:0031526 | brush border membrane(GO:0031526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.0 | 37.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.8 | 5.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 4.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 0.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.2 | 0.6 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 2.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 2.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 4.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 1.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 3.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 1.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 4.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 3.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 5.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 5.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 3.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 4.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 3.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 2.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 3.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 2.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 5.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |